MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD

C. R. Jack, M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. O'Brien, R. Cha, D. Knopman, R. C. Petersen

Research output: Contribution to journalArticlepeer-review

247 Scopus citations

Fingerprint

Dive into the research topics of 'MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD'. Together they form a unique fingerprint.

Medicine & Life Sciences